Determination of fleroxacin in pure and tablet forms by liquid chromatography and derivative UV-spectrophotometry

被引:0
作者
Kowalczuk, D [1 ]
Hopkala, H [1 ]
机构
[1] Med Univ, Dept Med Chem, PL-20093 Lublin, Poland
关键词
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Derivative UV-spectrophotometric and liquid chromatographic (LC) methods for fleroxacin determination were validated. In the spectrophotometric assay, first-, second-, third-, and fourth-order measurements were applied with the use of peak-zero and peak-peak techniques. The linear correlation between amplitude of the peak and concentration of the examined drug ranged from 2.0 to 12.0 mug/mL. An isocratic LC analysis was performed on a Purospher ODS column with an acidic mobile phase containing tetrabutylammonium hydroxide. Measurements were made at a wavelength of 285 nm with 4-aminobenzoic acid (PABA) as internal standard. The calibration curve was linear (r=0.9999) in the studied range of concentration (1.0-10.0 mug/mL). The accuracy (mean recovery, about 100%), precision (relative standard deviation <1%), selectivity, and sensitivity of the elaborated methods were satisfactory.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 7 条
  • [1] High-performance liquid chromatographic assay of fleroxacin in human serum using fluorescence detection
    Djurdjevic, P
    Jelickic-Stankov, M
    Laban, A
    [J]. TALANTA, 2001, 55 (03) : 631 - 638
  • [2] FUNK W, 1995, QUALITY ASSURANCE AN
  • [3] Rapid and simple determination of fleroxacin in rat plasma using a solid-phase extraction column
    Hobara, N
    Kameya, H
    Hokama, N
    Ohshiro, S
    Sakanashi, M
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1997, 703 (1-2): : 279 - 283
  • [4] Determination of fleroxacin in human serum and in dosage forms by derivative UV spectrophotometry
    Jelikic-Stankov, M
    Odovic, J
    Stankov, D
    Djurdjevic, P
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) : 145 - 150
  • [5] Kuhlmann J., 1998, QUINOLONE ANTIBACTER
  • [6] Long GL, 1983, ANAL CHEM, V55, p712A, DOI [DOI 10.1021/AC00258A001, 10.1021/ac00258a001]
  • [7] Milovanovic L, 2001, PHARMAZIE, V56, P150